Medication Beliefs, HIV-Related Stigmatization, and Adherence to Antiretroviral Therapy: An Examination of Alternative Models

References

• Center for Disease Control and Prevention. Estimated HIV Incidence and Prevalence in the United States, 2010–2016. HIV Surveillance Supplemental Report. 2019;24(1).
   Google Scholar
• Bezabhe WM, Chalmers L, Bereznicki LR, et al. Adherence to antiretroviral therapy and virologic failure: a meta-analysis. Medicine. 2016;95(15):e3361. doi:10.1097/MD.0000000000003361.
   PubMed Web of Science ®Google Scholar
• Gunthard HF, Saag MS, Benson CA, et al. Antiretroviral drugs for treatment and prevention of hiv infection in adults: 2016 recommendations of the International Antiviral Society-USA panel. J Am Med Assoc. 2016;316(2):191–210. doi:10.1001/jama.2016.8900.
   PubMed Web of Science ®Google Scholar
• Devereux HL, Youle M, Johnson MA, et al. Rapid decline in detectability of HIV-1 drug resistance mutations after stopping therapy. AIDS. 1999;13(18):123–127. doi:10.1097/00002030-199912240-00001.
   Web of Science ®Google Scholar
• Durant J, Clevenbergh P, Halfon P, et al. Drug-resistance genotyping in HIV-1 therapy: the VIRADAPT randomised controlled trial. Lancet. 1999;353(9171):2195–2199. doi:10.1016/S0140-6736(98)12291-2.
   PubMed Web of Science ®Google Scholar
• Kalichman SC, Kalichman MO, Cherry C. Forget about forgetting: structural barriers and severe non-adherence to antiretroviral therapy. AIDS Care. 2017;29(4):418–422. doi:10.1080/09540121.2016.1220478.
   PubMed Web of Science ®Google Scholar
• Langebeek N, Gisolf EH, Reiss P, et al. Predictors and correlates of adherence to combination antiretroviral therapy (ART) for chronic HIV infection: a meta-analysis. BMC Med. 2014;12:142. doi:10.1186/PREACCEPT-1453408941291432.
   PubMed Web of Science ®Google Scholar
• Tapp C, Milloy MJ, Kerr T, et al. Female gender predicts lower access and adherence to antiretroviral therapy in a setting of free healthcare. BMC Infect Dis. 2011;11:86.
   PubMed Web of Science ®Google Scholar
• Kalichman SC, Kalichman MO. HIV-related stress and life chaos mediate the association between poverty and medication adherence among people living with HIV/AIDS. J Clin Psychol Med Settings. 2016;23(4):420–430. doi:10.1007/s10880-016-9481-8.
   PubMed Web of Science ®Google Scholar
• Weiser SD, Frongillo EA, Ragland K, et al. Food insecurity is associated with incomplete HIV RNA suppression among homeless and marginally housed HIV-infected individuals in San Francisco. J Gen Intern Med. 2009;24(1):14–20. doi:10.1007/s11606-008-0824-5.
   PubMed Web of Science ®Google Scholar
• De Ridder DTD, De Wit JBF. Self-regulation in health behavior: concepts, theories, and central issues. In: de Ridder DTD, de Wit JBF, eds. Self-Regulation in Health Behavior. England: John Wiley & Sons, Ltd.; 2006:1–23.
   Google Scholar
• Horne R. Representations of medication and treatment: advances in theory and measurement. In: Petrie KJ, Weinman JA, eds. Perceptions of health and illness: current research and applications. Amsterdam, The Netherlands: Harwood Academic; 1997:155–188.
   Google Scholar
• Horne R. Treatment perceptions and self-regulation. In: Cameron LD, Leventhal H, eds. The self-regulation of health and illness behaviour. London, UK: Routledge; 2003:138–153.
   Google Scholar
• Horne R, Buick D, Fisher M, et al. Doubts about necessity and concerns about adverse effects: identifying the types of beliefs that are associated with non-adherence to HAART. Int J STD AIDS. 2004;15(1):38–44. doi:10.1258/095646204322637245.
   PubMed Web of Science ®Google Scholar
• Horne R, Chapman SC, Parham R, et al. Understanding patients’ adherence-related beliefs about medicines prescribed for long-term conditions: a meta-analytic review of the necessity-concerns framework. PLoS One. 2013;8(12):e80633. doi:10.1371/journal.pone.0080633.
   PubMed Web of Science ®Google Scholar
• Leventhal H, Meyer D, Nerenz D. The common sense representation of illness danger. In: Rachman S, ed. Medical psychology. New York, NY: Pergamon; 1980:7–30.
   Google Scholar
• Leventhal H, Diefenbach M, Leventhal E. Illness cognition: using common sense to understand treatment adherence and affect cognition interactions. Cogn Ther Res. 1992;16(2):143–163. doi:10.1007/BF01173486.
   Web of Science ®Google Scholar
• Joint United Nations Programme on HIV/AIDS. Report on the global AIDS epidemic. 2008. http://www.unaids.org/sites/default/files/media_asset/jc1510_2008globalreport_en_0.pdf
   Google Scholar
• Earnshaw VA, Chaudoir SR. From conceptualizing to measuring HIV stigma: a review of HIV stigma mechanism measures. AIDS Behav. 2009;13(6):1160–1177. doi:10.1007/s10461-009-9593-3.
   PubMed Web of Science ®Google Scholar
• Lowther K, Selman L, Harding R, et al. Experience of persistent psychological symptoms and perceived stigma among people with HIV on antiretroviral therapy (ART): a systematic review. Int J Nurs Stud. 2014;51(8):1171–1189. doi:10.1016/j.ijnurstu.2014.01.015.
   PubMed Web of Science ®Google Scholar
• Sweeney SM, Vanable PA. The association of HIV-related stigma to HIV medication adherence: a systematic review and synthesis of the literature. AIDS Behav. 2016;20(1):29–50. doi:10.1007/s10461-015-1164-1.
   PubMed Web of Science ®Google Scholar
• Kalichman SC, Eaton L, Kalichman MO, et al. Medication beliefs mediate the association between medical mistrust and antiretroviral adherence among African Americans living with HIV/AIDS. J Health Psychol. 2015;23:269–279.
   Google Scholar
• Kalichman SC, Eaton L, Kalichman MO, et al. Race-based medical mistrust, medication beliefs and HIV treatment adherence: test of a mediation model in people living with HIV/AIDS. J Behav Med. 2016;39(6):1056–1064. doi:10.1007/s10865-016-9767-1.
   PubMed Web of Science ®Google Scholar
• Gauchet A, Tarquinio C, Fischer G. Psychosocial predictors of medication adherence among persons living with HIV. Int J Behav Med. 2007;14(3):141–150. doi:10.1007/BF03000185.
   PubMed Web of Science ®Google Scholar
• Peyre M, Gauchet A, Roustit M, et al. Influence of the first consultation on adherence to antiretroviral therapy for HIV-infected patients. Open AIDS J. 2016;10(1):182–189. doi:10.2174/1874613601610010182.
   PubMedGoogle Scholar
• Eaton LA, Driffin DD, Kegler C, et al. Acknowledging the role of stigma and medical mistrust in engagement in routine health care among Black men who have sex with men. Am J Public Health. 2015;105(2):e75–e82. doi:10.2105/AJPH.2014.302322.
   PubMed Web of Science ®Google Scholar
• Naughton JD, Vanable PA. HIV stigmatization among healthcare providers: review of the evidence and implications for HIV care. In: Liamputtong P, ed. Stigma, discrimination and living with HIV/AIDS: a cross-cultural perspective. Dordrecht, The Netherlands: Springer; 2013:97–114.
   Google Scholar
• Sweeney SM. Understanding Mediators of the Relationship Between HIV-Related Stigma and Medication Adherence Among People Living with HIV [dissertation]. Syracuse, NY: Syracuse University; 2016.
   Google Scholar
• Earnshaw VA, Smith LR, Chaudoir SR, et al. HIV stigma mechanisms and well-being among PLWH: a test of the HIV stigma framework. AIDS Behav. 2013;17(5):1785–1795. doi:10.1007/s10461-013-0437-9.
   PubMed Web of Science ®Google Scholar
• Visser MJ, Kershaw T, Makin JD, et al. Development of parallel scales to measure HIV-related stigma. AIDS Behav. 2008;12(5):759–771. doi:10.1007/s10461-008-9363-7.
   PubMed Web of Science ®Google Scholar
• Berger BE, Ferrans CE, Lashley FR. Measuring stigma in people with HIV: psychometric assessment of the HIV stigma scale. Res Nurs Health. 2001;24(6):518–529. doi:10.1002/nur.10011.
   PubMed Web of Science ®Google Scholar
• Horne R, Weinman J, Hankins M. The beliefs about medicines questionnaire: the development and evaluation of a new method for assessing the cognitive representation of medication. Psychol Health. 1999;14(1):1–24. doi:10.1080/08870449908407311.
   Web of Science ®Google Scholar
• Simoni JM, Kurth AE, Pearson CR, et al. Self-report measures of antiretroviral therapy adherence: a review with recommendations for HIV research and clinical management. AIDS Behav. 2006;10(3):227–245. doi:10.1007/s10461-006-9078-6.
   PubMed Web of Science ®Google Scholar
• Muthén LK, Muthén BO. Mplus user’s guide. 6th ed. Los Angeles, CA: Muthén & Muthén; 1998-2015.
   Google Scholar
• Akaike H. A new look at the statistical model identification. IEEE Trans Automat Contr. 1974;19(6):716–723. doi:10.1109/TAC.1974.1100705.
   Web of Science ®Google Scholar
• Sclove SL. Application of model-selection criteria to some problems in multivariate-analysis. Psychometrika. 1987;52(3):333–343. doi:10.1007/BF02294360.
   Web of Science ®Google Scholar
• Kline RB. Principles and practice of structural equation modeling (3rd ed.). New York, NY: Guilford Press; 2011.
   Google Scholar
• Raftery AE. Bayesian model selection in structural equation models. In: Bollen KA, Long JS, eds. Testing structural equation models. Newbury Park, CA: Sage; 1993:163–180.
   Google Scholar
• Hayes AF. Introduction to mediation, moderation and conditional process analysis: a regression-based approach. New York, NY: Guilford Press; 2013.
   Google Scholar
• Arnsten JH, Demas PA, Farzadegan H, et al. Antiretroviral therapy adherence and viral suppression in HIV-infected drug users: comparison of self-report and electronic monitoring. Clin Infect Dis. 2001;33(8):1417–1423. doi:10.1086/323201.
   PubMed Web of Science ®Google Scholar
• Wagner G, Miller LG. Is the influence of social desirability on patients’ self-reported adherence overrated? J Acquir Immune Defic Syndr. 2004;35(2):203–204. doi:10.1097/00126334-200402010-00016.
   PubMed Web of Science ®Google Scholar
• Hickey MD, Salmen CR, Tessler RA, et al. Antiretroviral concentrations in small hair samples as a feasible marker of adherence in rural Kenya. J Acquir Immune Defic Syndr. 2014;66(3):311–315. doi:10.1097/QAI.0000000000000154.
   PubMed Web of Science ®Google Scholar
• Gandhi M, Ameli N, Bacchetti P, et al. Atazanavir concentration in hair is the strongest predictor of outcomes on antiretroviral therapy. Clin Infect Dis. 2011;52(10):1267–1275. doi:10.1093/cid/cir131.
   PubMed Web of Science ®Google Scholar
• Magnus M, Herwehe J, Wilbright W, et al. The validity of clinic-based samples in approximating out-of-care HIV-infected populations. AIDS Care. 2014;26(3):367–371. doi:10.1080/09540121.2013.824537.
   PubMed Web of Science ®Google Scholar